NeuroPace, Inc. (NPCE)
14.90
+0.15
(+1.02%)
USD |
NASDAQ |
Sep 04, 16:00
14.87
-0.03
(-0.20%)
After-Hours: 20:00
NeuroPace Research and Development Expense (Quarterly) : 6.898M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.898M |
| March 31, 2026 | 7.189M |
| December 31, 2025 | 7.027M |
| September 30, 2025 | 6.576M |
| June 30, 2025 | 6.845M |
| March 31, 2025 | 7.44M |
| December 31, 2024 | 6.05M |
| September 30, 2024 | 5.754M |
| June 30, 2024 | 6.065M |
| March 31, 2024 | 5.784M |
| December 31, 2023 | 5.377M |
| September 30, 2023 | 4.795M |
| June 30, 2023 | 5.343M |
| Date | Value |
|---|---|
| March 31, 2023 | 5.263M |
| December 31, 2022 | 5.089M |
| September 30, 2022 | 5.611M |
| June 30, 2022 | 5.669M |
| March 31, 2022 | 5.577M |
| December 31, 2021 | 5.345M |
| September 30, 2021 | 4.329M |
| June 30, 2021 | 4.437M |
| March 31, 2021 | 4.10M |
| December 31, 2020 | 3.919M |
| September 30, 2020 | 3.691M |
| June 30, 2020 | 3.252M |
| March 31, 2020 | 4.833M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | 46.93M |
| CVRx, Inc. | 3.13M |
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |